Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
The Oncologist|August 19, 2018
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor BiologyGaia Griguolo, Stephane Pouderoux, Maria Vittoria Dieci, et al.BMC Cancer|February 1, 2019
The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastasesAmélie Darlix, Christophe Hirtz, Simon Thezenas, et al.BMC Cancer|July 16, 2021
Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancerMarie Viala, Nelly Firmin, Célia Touraine, et al.Journal of Pharmaceutical and Biomedical Analysis|July 6, 2020
Liquid chromatography-tandem mass spectrometric assay for the quantification of CDK4/6 inhibitors in human plasma in a clinical context of drug-drug interactionFanny Leenhardt, Matthieu Gracia, Catherine Perrin, et al.Breast Cancer Research and Treatment|May 12, 2016
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastasesWilliam Jacot, Elvire Pons, Jean-Sébastien Frenel, et al.Bulletin Du Cancer|January 4, 2022
[A 2021 inventory in oncology news]Jacques-Olivier Bay, Carole Bouleuc, Nelly Firmin, et al.Bulletin Du Cancer|December 18, 2022
[A 2022 inventory in oncology news]Jacques-Olivier Bay, Carole Bouleuc, Christophe Caux, et al.Bulletin Du Cancer|January 6, 2024
[A 2023 inventory in oncology news]Jacques-Olivier Bay, Benjamin Auberger, Carole Bouleuc, et al.Pharmaceutics|April 23, 2022
Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug-Drug Interactions Are the Usual SuspectsFanny Leenhardt, Frédéric Fiteni, Ludovic Gauthier, et al.Bulletin Du Cancer|December 20, 2025
[A 2025 inventory in oncology news]Stéphane Vignot, Audrey Bellesoeur, Delphine Borchiellini, et al.Pageof 5